Literature DB >> 17235727

Clinical characteristics of a second small nodule(s) associated with cT1-2N0M0 non-small-cell lung cancer.

Ho Il Yoon1, Jae-Jun Yim, Choon-Taek Lee, Young Whan Kim, Sung Koo Han, Young-Soo Shim, Young Tae Kim, Sook Whan Sung, Joo Hyun Kim, Chul-Gyu Yoo.   

Abstract

When a patient with cT(1-2)N(0)M(0) stage non-small-cell lung cancer (NSCLC) has a second small nodule(s), the treatment plan and prognosis depend largely on whether the nodule is benign or malignant. However, the incidence of malignancy of nodules associated with N(0) and M(0) NSCLC is unknown. Furthermore, predictive factors of malignancy have not been defined. Thus, we evaluated the nature of nodules that were less than 15 mm in diameter associated with stage T(1-2)N(0)M(0), and tried to identify clinical and radiologic factors predictive of malignancy. The study population consisted of 39 patients with T(1-2)N(0)M(0) NSCLC and a second nodule(s) less than 1.5 cm and who had received curative resection. Medical records and radiologic findings, including CT scans of the chest, were retrospectively reviewed. Nodules were finally diagnosed as benign in 85% and malignant in 15%. No significant differences in terms of gender, age, preoperative carcinoembryonic antigen (CEA) level, cell type, pathologic stages, shape, size, location and number of nodules, or the presence of calcification around nodules was observed between benign and malignant groups. We suggest that if primary NSCLC is resectable, an effort should be made to confirm the pathologic diagnosis of nodules. If histologic findings in nodules are not available, surgical resection should be actively considered, especially when nodules < 1.5 cm are associated with N(0) or M(0) NSCLCs.

Entities:  

Mesh:

Year:  2006        PMID: 17235727     DOI: 10.1007/s00408-005-2593-9

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  22 in total

1.  Lung cancer--time to move on from chemotherapy.

Authors:  Desmond N Carney
Journal:  N Engl J Med       Date:  2002-01-10       Impact factor: 91.245

2.  Evaluation of primary pulmonary carcinoid tumors using FDG PET.

Authors:  J J Erasmus; H P McAdams; E F Patz; R E Coleman; V Ahuja; P C Goodman
Journal:  AJR Am J Roentgenol       Date:  1998-05       Impact factor: 3.959

Review 3.  Evaluation and management of solitary and multiple pulmonary nodules.

Authors:  G A Lillington; C I Caskey
Journal:  Clin Chest Med       Date:  1993-03       Impact factor: 2.878

4.  Cancer statistics, 2005.

Authors:  Ahmedin Jemal; Taylor Murray; Elizabeth Ward; Alicia Samuels; Ram C Tiwari; Asma Ghafoor; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2005 Jan-Feb       Impact factor: 508.702

5.  Early Lung Cancer Action Project: overall design and findings from baseline screening.

Authors:  C I Henschke; D I McCauley; D F Yankelevitz; D P Naidich; G McGuinness; O S Miettinen; D M Libby; M W Pasmantier; J Koizumi; N K Altorki; J P Smith
Journal:  Lancet       Date:  1999-07-10       Impact factor: 79.321

6.  Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis.

Authors:  M K Gould; C C Maclean; W G Kuschner; C E Rydzak; D K Owens
Journal:  JAMA       Date:  2001-02-21       Impact factor: 56.272

7.  Pulmonary tuberculoma evaluated by means of FDG PET: findings in 10 cases.

Authors:  J M Goo; J G Im; K H Do; J S Yeo; J B Seo; H Y Kim; J K Chung
Journal:  Radiology       Date:  2000-07       Impact factor: 11.105

8.  The solitary pulmonary nodule. Assessment, diagnosis, and management.

Authors:  N F Khouri; M A Meziane; E A Zerhouni; E K Fishman; S S Siegelman
Journal:  Chest       Date:  1987-01       Impact factor: 9.410

9.  Survival and prognostic factors in resected cN2-pN0 non-small cell lung cancer.

Authors:  Hiroto Niizeki; Toshiaki Morikawa; Shunichi Okushiba; Satoshi Kondo; Hiroyuki Katoh
Journal:  Ann Thorac Cardiovasc Surg       Date:  2004-02       Impact factor: 1.520

10.  Predictive factors for survival in surgically resected clinical IA peripheral adenocarcinoma of the lung.

Authors:  Yukinori Sakao; Takahiko Nakazono; Toru Sakuragi; Masafumi Natsuaki; Tsuyoshi Itoh
Journal:  Ann Thorac Surg       Date:  2004-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.